Switch to:

Arena Pharmaceuticals Debt-to-Revenue

: 9.31 As of Sep. 2019
View and export this data going back to 2000. Start your Free Trial

Debt-to-Revenue measures a company's ability to pay off its debt.

Arena Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $3.7 Mil. Arena Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $46.6 Mil. Arena Pharmaceuticals's annualized Revenue for the quarter that ended in Sep. 2019 was $5.4 Mil. Arena Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in Sep. 2019 was 9.31.


Arena Pharmaceuticals Debt-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arena Pharmaceuticals Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Debt-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 5.09 0.71 2.89 2.93

Arena Pharmaceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Debt-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 1.52 0.02 12.51 9.31

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arena Pharmaceuticals Debt-to-Revenue Distribution

* The bar in red indicates where Arena Pharmaceuticals's Debt-to-Revenue falls into.



Arena Pharmaceuticals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Arena Pharmaceuticals's Debt-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.283 + 49.426) / 17.97
=2.93

Arena Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in Sep. 2019 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.676 + 46.617) / 5.4
=9.31

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2019) Revenue data.


Arena Pharmaceuticals Debt-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)